CNBC August 20, 2025
Key Points
– The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, a new option for Americans to manage their weight.
– Any patient can now purchase a Signos membership to access its system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom to offer personalized, real-time data and lifestyle recommendations for healthy weight management.
– The system can be used in combination with or after other existing weight loss treatments such as GLP-1s or bariatric surgery.
The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option...
Today's Sponsors
Today's Sponsor